Cytokinetics, Inc. (CYTK)
77.09
+0.25
(+0.33%)
USD |
NASDAQ |
Aug 24, 16:00
77.09
0.00 (0.00%)
After-Hours: 19:58
Cytokinetics 1 Year Total Returns (Daily) : 101.9% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 101.9% |
| August 20, 2026 | 106.8% |
| August 19, 2026 | 105.4% |
| August 18, 2026 | 95.38% |
| August 17, 2026 | 96.20% |
| August 14, 2026 | 91.45% |
| August 13, 2026 | 99.16% |
| August 12, 2026 | 120.5% |
| August 11, 2026 | 130.1% |
| August 10, 2026 | 127.2% |
| August 07, 2026 | 117.8% |
| August 06, 2026 | 131.6% |
| August 05, 2026 | 118.1% |
| August 04, 2026 | 114.9% |
| August 03, 2026 | 108.4% |
| July 31, 2026 | 104.9% |
| July 30, 2026 | 122.3% |
| July 29, 2026 | 118.3% |
| July 28, 2026 | 116.9% |
| July 27, 2026 | 116.8% |
| July 24, 2026 | 116.4% |
| July 23, 2026 | 116.0% |
| July 22, 2026 | 118.0% |
| July 21, 2026 | 119.5% |
| July 20, 2026 | 112.5% |
| Date | Value |
|---|---|
| July 17, 2026 | 106.2% |
| July 16, 2026 | 107.8% |
| July 15, 2026 | 117.4% |
| July 14, 2026 | 112.4% |
| July 13, 2026 | 122.2% |
| July 10, 2026 | 131.9% |
| July 09, 2026 | 135.0% |
| July 08, 2026 | 147.8% |
| July 07, 2026 | 156.5% |
| July 06, 2026 | 146.9% |
| July 02, 2026 | 151.7% |
| July 01, 2026 | 153.4% |
| June 30, 2026 | 157.8% |
| June 29, 2026 | 163.1% |
| June 26, 2026 | 142.4% |
| June 25, 2026 | 144.0% |
| June 24, 2026 | 143.1% |
| June 23, 2026 | 145.1% |
| June 22, 2026 | 144.1% |
| June 18, 2026 | 140.7% |
| June 17, 2026 | 140.0% |
| June 16, 2026 | 122.6% |
| June 15, 2026 | 107.6% |
| June 12, 2026 | 111.3% |
| June 11, 2026 | 109.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Krystal Biotech, Inc. | 137.9% |
| Ionis Pharmaceuticals, Inc. | 38.18% |
| Bristol Myers Squibb Co. | 44.96% |
| Gilead Sciences, Inc. | 29.10% |
| Rigel Pharmaceuticals, Inc. | 9.29% |